|
|
Volumn 60, Issue 1, 2011, Pages
|
|
Comment on: Lin et al. (2010) immune cell-derived c3 is required for autoimmune diabetes induced by multiple low doses of streptozotocin. Diabetes;59: 2247-2252
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ALBUMIN;
COLLAGEN TYPE 4;
COMPLEMENT COMPONENT C3;
CREATININE;
FIBRONECTIN;
GLUCOSE;
MANNOSE BINDING LECTIN;
MESSENGER RNA;
STREPTOZOCIN;
TRANSFORMING GROWTH FACTOR BETA;
VASCULOTROPIN A;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
AUTOIMMUNE DISEASE;
BODY WEIGHT;
COMPLEMENT SYSTEM;
CONTROLLED STUDY;
DIABETES MELLITUS;
FEMALE;
GENE EXPRESSION;
GLOMERULUS BASEMENT MEMBRANE;
GLUCOSE BLOOD LEVEL;
IMMUNOCOMPETENT CELL;
KIDNEY;
KNOCKOUT MOUSE;
LETTER;
LOW DRUG DOSE;
MOUSE;
MULTIPLE DRUG DOSE;
NONHUMAN;
OUTCOMES RESEARCH;
PRIORITY JOURNAL;
STREPTOZOCIN DIABETES;
URINE LEVEL;
WILD TYPE;
ANIMALS;
BASEMENT MEMBRANE;
BLOOD GLUCOSE;
COMPLEMENT C3;
CROSSES, GENETIC;
DIABETES MELLITUS, EXPERIMENTAL;
DIABETIC NEPHROPATHIES;
KIDNEY GLOMERULUS;
MANNOSE-BINDING LECTIN;
MICE;
MICE, INBRED C57BL;
MICE, KNOCKOUT;
|
|
EID: 78751551698
PISSN: 00121797
EISSN: 1939327X
Source Type: Journal
DOI: 10.2337/db10-1298 Document Type: Letter |
|
Times cited : (3)
|
|
References (3)
|
